Search research articles
Contact Us
Filters
Showing results (131-140 of 137) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 137 results.
BMJ Open
|
October 26, 2024
Protocol for a phase 2 study of bosutinib for amyotrophic lateral sclerosis using real-world data: induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (iDReAM) study
Keiko Imamura, Yuishin Izumi, Naohiro Egawa, et al.
BMJ Open
|
July 1, 2021
Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations
Takayuki Kondo, Haruhiko Banno, Taro Okunomiya, et al.
Nature Communications
|
February 17, 2021
microRNA-33 maintains adaptive thermogenesis via enhanced sympathetic nerve activity
Takahiro Horie, Tetsushi Nakao, Yui Miyasaka, et al.
Science Translational Medicine
|
May 26, 2017
The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis
Keiko Imamura, Yuishin Izumi, Akira Watanabe, et al.
Science Translational Medicine
|
June 7, 2013
Response to comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells"
Naohiro Egawa, Shiho Kitaoka, Kayoko Tsukita, et al.
Science Translational Medicine
|
August 3, 2012
Drug screening for ALS using patient-specific induced pluripotent stem cells
Naohiro Egawa, Shiho Kitaoka, Kayoko Tsukita, et al.
Cell Stem Cell
|
February 26, 2013
Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness
Takayuki Kondo, Masashi Asai, Kayoko Tsukita, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 137) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 137 results.
BMJ Open
|
October 26, 2024
Protocol for a phase 2 study of bosutinib for amyotrophic lateral sclerosis using real-world data: induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (iDReAM) study
Keiko Imamura, Yuishin Izumi, Naohiro Egawa, et al.
BMJ Open
|
July 1, 2021
Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations
Takayuki Kondo, Haruhiko Banno, Taro Okunomiya, et al.
Nature Communications
|
February 17, 2021
microRNA-33 maintains adaptive thermogenesis via enhanced sympathetic nerve activity
Takahiro Horie, Tetsushi Nakao, Yui Miyasaka, et al.
Science Translational Medicine
|
May 26, 2017
The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis
Keiko Imamura, Yuishin Izumi, Akira Watanabe, et al.
Science Translational Medicine
|
June 7, 2013
Response to comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells"
Naohiro Egawa, Shiho Kitaoka, Kayoko Tsukita, et al.
Science Translational Medicine
|
August 3, 2012
Drug screening for ALS using patient-specific induced pluripotent stem cells
Naohiro Egawa, Shiho Kitaoka, Kayoko Tsukita, et al.
Cell Stem Cell
|
February 26, 2013
Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness
Takayuki Kondo, Masashi Asai, Kayoko Tsukita, et al.
Page
of 14